Multiple Myeloma Clinical Trial

Brilliant Study: Assessing Cognition in Myeloma Patients Undergoing Transplant

Summary

The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patients who undergo autologous stem cell transplant, and to determine if patients prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare applied Montreal Cognitive Assessment (MoCA) assessment.

View Full Description

Full Description

The overall objectives in this study are to identify patterns of cognitive impairment pre- and post-transplant, to assess the similarities of scores of the three cognitive assessments in myeloma patients who undergo autologous stem cell transplant, and to determine if patients prefer the self-assessment, Self-Administered Gerocognitive Exam (SAGE) or the healthcare applied Montreal Cognitive Assessment (MoCA) assessment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with multiple myeloma
Patients who will undergo pre-transplant evaluation with intentions to proceed to autologous stem cell transplant after stem cell collection.
Patients willing and able to understand and sign an informed consent form
Patients 18 yrs of age or older

Exclusion Criteria:

Patients with unstable psychiatric illness within the past 3 months of study enrollment.
Patients who are considered unable to perform study evaluations at the investigator's discretion.
Patients who are unable to read. (If patients require reading glasses, they must be worn at time of test.)
Patients who do not proceed to stem cell transplant within 60 days of stem cell collection will be excluded from study.
Patients who receive more than one cycle of chemotherapy between the time of stem cell collection and transplant will be excluded from study.

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

50

Study ID:

NCT03355235

Recruitment Status:

Completed

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Wake Forest University Health Sciences
Winston-Salem North Carolina, 27157, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Myeloma

Estimated Enrollment:

50

Study ID:

NCT03355235

Recruitment Status:

Completed

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider